Varex Imaging Co. (NASDAQ:VREX - Free Report) - Analysts at B. Riley issued their Q1 2026 earnings per share (EPS) estimates for shares of Varex Imaging in a research note issued to investors on Monday, May 12th. B. Riley analyst A. Schock anticipates that the company will post earnings of $0.08 per share for the quarter. B. Riley has a "Strong-Buy" rating on the stock. The consensus estimate for Varex Imaging's current full-year earnings is $0.53 per share. B. Riley also issued estimates for Varex Imaging's Q3 2026 earnings at $0.11 EPS.
Varex Imaging (NASDAQ:VREX - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.12. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. The business had revenue of $212.90 million during the quarter, compared to analyst estimates of $206.76 million. During the same quarter in the previous year, the firm posted $0.16 EPS. The business's revenue for the quarter was up 3.3% compared to the same quarter last year.
VREX has been the subject of a number of other research reports. StockNews.com upgraded Varex Imaging from a "hold" rating to a "buy" rating in a research report on Friday, February 7th. Oppenheimer reduced their price target on Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a research report on Friday, February 7th.
Get Our Latest Stock Report on Varex Imaging
Varex Imaging Stock Performance
NASDAQ:VREX traded down $0.01 during midday trading on Tuesday, reaching $7.88. 429,526 shares of the company traded hands, compared to its average volume of 578,112. Varex Imaging has a twelve month low of $6.76 and a twelve month high of $16.93. The firm has a market capitalization of $324.66 million, a price-to-earnings ratio of -6.73 and a beta of 0.62. The company has a debt-to-equity ratio of 1.02, a current ratio of 4.36 and a quick ratio of 2.50. The company has a fifty day moving average price of $9.36 and a 200 day moving average price of $12.52.
Institutional Trading of Varex Imaging
A number of hedge funds and other institutional investors have recently modified their holdings of VREX. Aquatic Capital Management LLC bought a new stake in shares of Varex Imaging in the 4th quarter worth $25,000. Quadrant Capital Group LLC raised its stake in shares of Varex Imaging by 115.4% in the 4th quarter. Quadrant Capital Group LLC now owns 2,837 shares of the company's stock worth $41,000 after buying an additional 1,520 shares in the last quarter. Point72 Hong Kong Ltd bought a new stake in shares of Varex Imaging in the 4th quarter worth $48,000. Quarry LP bought a new stake in shares of Varex Imaging in the 1st quarter worth $63,000. Finally, KLP Kapitalforvaltning AS bought a new stake in shares of Varex Imaging in the 4th quarter worth $98,000.
Insiders Place Their Bets
In other news, SVP Kimberley E. Honeysett sold 4,007 shares of the business's stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $12.81, for a total value of $51,329.67. Following the sale, the senior vice president now owns 4,002 shares of the company's stock, valued at approximately $51,265.62. The trade was a 50.03% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Sunny Sanyal sold 8,749 shares of the business's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total value of $98,338.76. Following the completion of the sale, the chief executive officer now directly owns 190,193 shares in the company, valued at $2,137,769.32. This represents a 4.40% decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by insiders.
About Varex Imaging
(
Get Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Featured Stories
Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
